U.S. regulators on Friday approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause people anxiety and affect their social lives. The Food and Drug Administration approved Qbrexza for excessive underarm sweating and will be available in October. The drug is inside a cloth ... Read More »